Quantinuum Inc., a quantum computing company backed by Honeywell International Inc., has filed for an initial public offering seeking to raise 1.05 billion, reflecting continued investor interest in the potential of the technology despite recent market fluctuations. The company reported a net loss of 136.6 million for the quarter ending March 31st, an increase from the 30.5 million loss reported during the same period last year, while revenue decreased from 19.1 million to 5.2 million. Quantinuum is developing platforms for applications in chemistry, machine learning, cybersecurity, and drug discovery, and counts Amgen Inc. and Mitsui & Co. among its early users. Chief Executive Officer Rajeeb Hazra wrote to investors, outlining a goal for the company’s future: “We believe that we are executing a roadmap to the first commercial-scale, fully fault-tolerant quantum computer before the end of this decade, the Apollo system.”
Quantinuum IPO Targets 1.05 Billion Amidst Investor Enthusiasm
Quantinuum Inc. is targeting a valuation of 12.7 billion amid heightened investor interest in quantum computing technologies. The company intends to offer approximately 21 million shares, priced between 45 and 50 each, according to a filing with the US Securities and Exchange Commission. Despite a recent slowdown in the broader quantum computing stock rally, with shares of Rigetti Computing Inc. falling from a peak in October, Quantinuum’s move signals continued confidence in the sector’s long-term potential, particularly as artificial intelligence demands increasingly powerful processing capabilities. The company’s financial filings reveal a complex picture; revenue decreased from 19.1 million to 5.2 million compared to the 30.5 million reported during the same period last year. Quantinuum is actively building platforms for applications spanning chemistry, machine learning, and cybersecurity, and has secured early collaborations with major players like Amgen Inc. and Mitsui & Co. These partnerships suggest a move beyond theoretical research toward practical implementation. Honeywell International Inc. will retain significant influence, controlling 49% of the voting power post-IPO, with Cambridge Quantum holding 33%.
Honeywell & Cambridge Quantum Form Quantinuum; Government Funding Awarded
Quantinuum delivers high-performance quantum computation and is pursuing an initial public offering aiming to secure 1.05 billion. This financial move arrives alongside substantial government backing, with Quantinuum slated to receive 100 million from a 2 billion Commerce Department package designed to bolster US quantum firms. In exchange for this funding, the US government will acquire minority, non-controlling stakes in the supported companies, signaling a strategic national investment in the field. The company, formed by the 2021 merger of Honeywell Quantum Solutions’ hardware expertise and Cambridge Quantum’s software capabilities, is not yet profitable; filings reveal a net loss of 136.6 million on revenue of $5.2 million. Quantinuum works with Mitsui & Co. The company acknowledges risks related to scaling manufacturing and reliance on single-source suppliers for critical materials, but currently operates four commercial quantum computing systems, with a fifth planned for deployment in Singapore later this year.
We believe that we are executing a roadmap to the first commercial-scale, fully fault-tolerant quantum computer before the end of this decade, the Apollo system.
